Abstract
Serum total homocysteine (tHcy) has been implicated in promoting venous thromboembolic events and athero- sclerosis, manifested as coronary heart disease, stroke or peripheral arterial disease. Dietary supplementation with B vita- mins that lower tHcy concentrations was expected to reduce cardiovascular disease (CVD) risk. However, recent meta- analyses of prospective observational studies and randomized controlled trials failed to show a role of tHcy in the patho- genesis of vascular disease or a benefit of B vitamins in CVD events. This review analyzes recent data on the potential of tHcy to cause health problems (if any) and the role of vitamin B supplementation in preventing them.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
